FDA moves toward easing restrictions on certain peptides BioPharma Dive The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York RFK Jr. promotes peptides. Now the FDA weighs easing limits on the unproven chemicals The Human Lab Rats Injecting Themselves with Peptides Office for Science and Society McGill University Peptides Lack Reliable Safety Information, Watchdog Warns